This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Trial of Oxford COVID-19 vaccine starts in Brazil

Volunteers have begun taking part in Latin America’s first clinical trial for a vaccine against COVID-19.

Volunteers in Brazil have begun receiving a trial vaccine against COVID-19, in Latin America’s first phase 3 COVID-19 clinical trial.

The trial officially began on Saturday 20th June and will enrol 5,000 volunteers across the country. Vaccinations will take place in Sao Paulo, Rio de Janeiro and a site in the Northeast of Brazil.

The Brazilian Health Regulatory Agency (ANVISA) approved the inclusion of Brazil in the clinical trials on 2nd June, which are being conducted in partnership with AstraZeneca. The trial is being sponsored entirely by Brazilian entrepreneurs.

The full story is available on the University of Oxford website